This report discusses the importance of equitable access to medicines and vaccines, emphasizing its significance in achieving the Sustainable Development Goals. The Seventy-first World Health Assembly had previously considered a report on addressing global shortages and access to medicines and vaccines. This led to the request for a road map detailing WHO's work on access to these essential health products for the period 2019–2023.
The road map was developed with input from various levels of the Organization, considering existing governing body documents, budgeting, and relevant departmental strategies. It builds on numerous regional and national initiatives committed to improving access to quality medicines, vaccines, and health products.
The document outlines two strategic areas essential for supporting access to health products: ensuring the quality, safety, and efficacy of health products and improving equitable access to health products. Each strategic area describes specific activities, actions, and deliverables for the mentioned period.
A health systems approach is emphasized, detailing the importance of financing, governance, and a competent health workforce in improving access to health products. The document also highlights the need for transparency in clinical trials and price transparency through platforms like the Market Information for Access to Vaccines (MI4A).
You can submit a specific query to QUAMED experts by clicking on the button below. We will send relevant answers directly to your mailbox.
Submit Query
The information provided on this Web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development or the U.S. Government.
ISO 9001:2015 - FS766975
© 2025 - QUAMED
Content of this site is licensed under a Creative Commons License- BY Attribution